{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:37:33Z","timestamp":1791434253027,"version":"4.3.3"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","award":["848016005"],"award-info":[{"award-number":["848016005"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cgh.2026.01.013","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T15:44:55Z","timestamp":1769701495000},"page":"2273-2285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Tailored Treatment of Functional Dyspepsia With Nortriptyline: A Multicenter, Double-Blind, Placebo-Controlled Trial"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1788-2199","authenticated-orcid":false,"given":"Daan H.C.A.","family":"Bosch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9532-2576","authenticated-orcid":false,"given":"Abraham B.","family":"Beckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3582-2966","authenticated-orcid":false,"given":"Johanna T.W.","family":"Snijkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2040-2520","authenticated-orcid":false,"given":"Michelle H.M.A.","family":"Bosman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6747-6228","authenticated-orcid":false,"given":"Bjorn","family":"Winkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8780-476X","authenticated-orcid":false,"given":"Jean W.M.","family":"Muris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0273-8290","authenticated-orcid":false,"given":"Niek","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7547-1662","authenticated-orcid":false,"given":"Jacobus R.B.J.","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9666-5001","authenticated-orcid":false,"given":"Koen","family":"van Hee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5460-7014","authenticated-orcid":false,"given":"Cees H.M.","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram J.T.","family":"Haarhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1341-8540","authenticated-orcid":false,"given":"Ben J.M.","family":"Witteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5819-0116","authenticated-orcid":false,"given":"Ad A.M.","family":"Masclee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9856-9980","authenticated-orcid":false,"given":"Daniel","family":"Keszthelyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2026.01.013_bib1","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/gutjnl-2014-307843","article-title":"Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis","volume":"64","author":"Ford","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2026.01.013_bib2","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.cgh.2010.05.031","article-title":"What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis","volume":"8","author":"Ford","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.01.013_bib3","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1053\/j.gastro.2016.02.011","article-title":"Gastroduodenal disorders","volume":"150","author":"Stanghellini","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.01.013_bib4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/apt.12355","article-title":"Functional dyspepsia: the economic impact to patients","volume":"38","author":"Lacy","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2026.01.013_bib5","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/ajg.2017.154","article-title":"ACG and CAG clinical guideline: management of dyspepsia","volume":"112","author":"Moayyedi","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.01.013_bib6","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/gutjnl-2022-327737","article-title":"British Society of Gastroenterology guidelines on the management of functional dyspepsia","volume":"71","author":"Black","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2026.01.013_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14474","article-title":"Placebo response in pharmacological trials in patients with functional dyspepsia\u2013a systematic review and meta-analysis","volume":"35","author":"Bosman","year":"2023","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2026.01.013_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.12443","article-title":"Effectiveness of genotype-specific tricyclic antidepressant dosing in patients with major depressive disorder: a randomized clinical trial","volume":"6","author":"Vos","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cgh.2026.01.013_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/cpt.597","article-title":"Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update","volume":"102","author":"Hicks","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cgh.2026.01.013_bib10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/cts.12692","article-title":"Standardizing CYP2D6 genotype to phenotype translation: consensus recommendations from the clinical pharmacogenetics implementation consortium and Dutch Pharmacogenetics Working Group","volume":"13","author":"Caudle","year":"2020","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.cgh.2026.01.013_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2036.1999.00445.x","article-title":"Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index","volume":"13","author":"Talley","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2026.01.013_bib12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jval.2016.01.003","article-title":"Dutch tariff for the five-level version of EQ-5D","volume":"19","author":"M","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.cgh.2026.01.013_bib13","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cgh.2026.01.013_bib14","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.cgh.2026.01.013_bib15","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.gastro.2015.04.020","article-title":"Effect of amitriptyline and escitalopram on functional dyspepsia: a multicenter, randomized controlled study","volume":"149","author":"Talley","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.01.013_bib16","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/ije\/dyl129","article-title":"Sample size for cluster randomized trials: effect of coefficient of variation of cluster size and analysis method","volume":"35","author":"Eldridge","year":"2006","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.cgh.2026.01.013_bib19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S2468-1253(21)00023-6","article-title":"The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis","volume":"6","author":"Bosman","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.01.013_bib20","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S2468-1253(18)30303-0","article-title":"Low-dose imipramine for refractory functional dyspepsia: a randomised, double-blind, placebo-controlled trial","volume":"3","author":"Cheong","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.01.013_bib21","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1365-2036.2011.04775.x","article-title":"Randomised clinical trial: the effects of amitriptyline on drinking capacity and symptoms in patients with functional dyspepsia, a double-blind placebo-controlled study","volume":"34","author":"Braak","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2026.01.013_bib17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/jgh.13914","article-title":"Efficacy and safety of nortriptyline in functional dyspepsia in Asians: a randomized double-blind placebo-controlled trial","volume":"33","author":"Kaosombatwattana","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.01.013_bib22","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.cgh.2008.02.051","article-title":"Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial","volume":"6","author":"van Kerkhoven","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.01.013_bib23","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.3748\/wjg.v18.i42.6127","article-title":"Treatment of functional dyspepsia with sertraline: a double-blind randomized placebo-controlled pilot study","volume":"18","author":"Tan","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.01.013_bib18","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(23)01523-4","article-title":"Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"402","author":"Ford","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2026.01.013_bib24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0306-9877(86)90001-0","article-title":"Double blind: double talk or are there ways to do better research","volume":"21","author":"Ney","year":"1986","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.cgh.2026.01.013_bib25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jclinepi.2014.02.001","article-title":"A theoretical analysis showed that blinding cannot eliminate potential for bias associated with beliefs about allocation in randomized clinical trials","volume":"67","author":"Mathieu","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cgh.2026.01.013_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/ajcn\/nqy077","article-title":"Fat label compared with fat content: gastrointestinal symptoms and brain activity in functional dyspepsia patients and healthy controls","volume":"108","author":"Lee","year":"2018","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.cgh.2026.01.013_bib27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/gut.22.4.323","article-title":"Symptom relief and the placebo effect in the trial of an anti-peptic drug","volume":"22","author":"MacDonald","year":"1981","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2026.01.013_bib28","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S2468-1253(23)00317-5","article-title":"The effect of expectancy versus actual gluten intake on gastrointestinal and extra-intestinal symptoms in non-coeliac gluten sensitivity: a randomised, double-blind, placebo-controlled, international, multicentre study","volume":"9","author":"de Graaf","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.01.013_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2024.111658","article-title":"Treatment effects in pharmacological clinical randomized controlled trials are mainly due to placebo","volume":"179","author":"Schmidt","year":"2025","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cgh.2026.01.013_bib30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/j.gastro.2025.02.030","article-title":"Mebeverine and the influence of labeling in adolescents with irritable bowel syndrome or functional abdominal pain-NOS: a 2x2 randomized, placebo-controlled trial","volume":"169","author":"Rexwinkel","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.01.013_bib31","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0140-6736(02)07816-9","article-title":"Blinding in randomised trials: hiding who got what","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2026.01.013_bib32","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1176\/ajp.149.12.1730","article-title":"Side effects and the \"blindability\" of clinical drug trials","volume":"149","author":"White","year":"1992","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.cgh.2026.01.013_bib33","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/nmo.12289","article-title":"Adverse events appear to unblind clinical trials in irritable bowel syndrome","volume":"26","author":"Shah","year":"2014","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2026.01.013_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3959(02)00060-X","article-title":"Blinding effectiveness and association of pretreatment expectations with pain improvement in a double-blind randomized controlled trial","volume":"99","author":"Turner","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.cgh.2026.01.013_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015591","article-title":"Placebos without deception: a randomized controlled trial in irritable bowel syndrome","volume":"5","author":"Kaptchuk","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2026.01.013_bib36","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1097\/j.pain.0000000000002234","article-title":"Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial","volume":"162","author":"Lembo","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.cgh.2026.01.013_bib37","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.dld.2021.02.020","article-title":"Role of serum amitriptyline concentration and CYP2C19 polymorphism in predicting the response to low-dose amitriptyline in irritable bowel syndrome","volume":"53","author":"Zhou","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2026.01.013_bib38","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jclinepi.2021.02.022","article-title":"Measuring the success of blinding in placebo-controlled trials: should we be so quick to dismiss it?","volume":"135","author":"Webster","year":"2021","journal-title":"J Clin Epidemiol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526000418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526000418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:03:34Z","timestamp":1786017814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356526000418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1542356526000418"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2026.01.013","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tailored Treatment of Functional Dyspepsia With Nortriptyline: A Multicenter, Double-Blind, Placebo-Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2026.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}]}}